Edward L. Kaplan

Q: What Schools Are Affiliated With Edward L. Kaplan

Edward L. Kaplan is affiliated with the following schools: Oregon State University, University of Minnesota, Princeton University, Carnegie Mellon University, University of Chicago

Edward L. Kaplan's AcademicInfluence.com Rankings

Edward L. Kaplan

Mathematics

#1099

World Rank

#1866

Historical Rank

#474

USA Rank

Measure Theory

#3733

World Rank

#4401

Historical Rank

#1070

USA Rank

mathematics Degrees

Download Badge

Mathematics

Edward L. Kaplan's Degrees

PhD Mathematics University of Chicago

Why Is Edward L. Kaplan Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Edward Lynn Kaplan was a mathematician most famous for the Kaplan–Meier estimator, developed together with Paul Meier. Biography Edward Lynn Kaplan was born in Philadelphia, Pennsylvania, on May 11, 1920. His parents were Eugene V. Kaplan and Frances Rhodes Kaplan . He graduated from Swissvale High School in Swissvale, Pennsylvania, in 1937. He attended the Carnegie Institute of Technology from 1937 to 1941 and graduated with a bachelor's degree in mathematics in 1941. Three times—in 1939, 1940, and 1941—he was one of the five honorees in the nationwide William Lowell Putnam Mathematical Competition conducted by the American Mathematical Association. He was offered Westinghouse's Putnam Prize Scholar Scholarship in mathematics at Harvard but was unable to accept due to his involvement in war efforts. Kaplan was elected to three scholastic societies: Phi Kappa Phi, Sigma Xi, and the engineering society, Tau Beta Phi.

(See a Problem?)

Edward L. Kaplan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Practice guidelines for the diagnosis and management of skin and soft-tissue infections. (2005) (2166)
Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. (2002) (735)
Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. (1992) (682)
Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. (2012) (529)
Resurgence of acute rheumatic fever in the intermountain area of the United States. (1987) (506)
Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America (2012) (504)
Revision of the Jones Criteria for the Diagnosis of Acute Rheumatic Fever in the Era of Doppler Echocardiography: A Scientific Statement From the American Heart Association (2015) (445)
Guidelines for the Diagnosis of Rheumatic Fever: Jones Criteria, Updated 1992 Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, American Heart Association (1993) (335)
Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s (1992) (307)
Diagnosis and Management of Group A Streptococcal Pharyngitis: A Practice Guideline (1997) (303)
Apparent failures of endocarditis prophylaxis. Analysis of 52 cases submitted to a national registry. (1983) (224)
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. (1984) (175)
Prevention of Rheumatic Fever: A Statement Prepared by the Rheumatic Fever Committee of the Council on Rheumatic Fever and Congenital Heart Disease of the American Heart Association (1971) (146)
Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. (1989) (142)
Antistreptolysin O and Anti-Deoxyribonuclease B Titers: Normal Values for Children Ages 2 to 12 in the United States (1998) (129)
Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. (1988) (124)
Prevention of bacterial endocarditis. (1991) (122)
Once-Daily Therapy for Streptococcal Pharyngitis With Amoxicillin (1999) (108)
Global Assessment of Rheumatic Fever and Rheumatic Heart Disease at the Close of the Century Influences and Dynamics of Populations and Pathogens: A Failure to Realize Prevention? (1993) (102)
Diagnosis of strep throat in adults: are clinical criteria really good enough? (2002) (89)
Potential Mechanisms for Failure to Eradicate Group A Streptococci From the Pharynx (1999) (79)
A Collaborative Study of Infective Endocarditis in the 1970s (1979) (63)
A.H.A. committee report. Prevention of rheumatic fever. (1977) (51)
Incidence of rheumatic fever and prevalence of rheumatic heart disease in India. (1994) (50)
Streptococcal Upper Respiratory Tract Infections and Psychosocial Stress Predict Future Tic and Obsessive-Compulsive Symptom Severity in Children and Adolescents with Tourette Syndrome and Obsessive-Compulsive Disorder (2010) (45)
Pathogenesis of acute rheumatic fever and rheumatic heart disease: evasive after half a century of clinical, epidemiological, and laboratory investigation (2004) (42)
Trend: Podcasting in Academic and Corporate Learning (2005) (41)
The fall and rise of rheumatic fever in the United States: a commentary. (1988) (40)
Treatment of infective endocarditis due to viridans streptococci, This statement was prepared by the ad hoc subcommittee on Treatment of Bacterial endocarditis of the American Heart Association Council on Cardiovascular Disease in the Young. (1981) (36)
Antecedent streptococcal infection in acute rheumatic fever. (2006) (30)
Prevention of bacterial endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Bacterial Endocarditis of the Council on Cardiovascular Diseases in the Young of the American Heart Association. (1985) (28)
Rapid antigen detection in the diagnosis of Group A streptococcal pyoderma: influence of a “learning curve effect” on sensitivity and specificity (1989) (25)
Reappearance of rheumatic fever. (1989) (24)
Effects of Cardiopulmonary Bypass on the Phagocytic and Bactericidal Capacities of Polymorphonuclear Leukocytes (1968) (22)
Group A Streptococcal Bacteremia in a Mid-South Children's Hospital (1993) (22)
Bacterial endocarditis in the neonate. (1972) (21)
Epidemiological approaches to understanding the pathogenesis of rheumatic fever. (1985) (21)
Rheumatic fever in Minnesota. II. Evaluation of hospitalized patients and utilization of a State Rheumatic Fever Registry. (1979) (16)
Streptolysin O: Suppression of Its Antigenicity by Lipids Extracted from Skin 1 (1974) (14)
Advanced Atrioventricular Block in a 39‐Year‐Old Man with Acute Rheumatic Fever (1998) (14)
Infarction Patterns in Endocardial Fibroelastosis (1966) (11)
Serum cholesterol levels in patients with acute rheumatic fever. (1993) (11)
Cholesterol Inhibition of Streptolysin O Toxicity for Myocardial Cells in Tissue Culture (1981) (10)
Bacterial endocarditis prophylaxis--tradition or necessity? (1986) (9)
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. (2007) (9)
Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. (1984) (9)
PANDAS? Or PAND? Or both? Or neither? (2000) (9)
Prevention of bacterial endo carditis (1977) (9)
Acute rheumatic fever in Tunisia. Serotypes of group A streptococci associated with rheumatic fever. (1997) (8)
Rheumatic heart disease in rural Pakistan (2004) (8)
Appropriate use of antibiotics: pharyngitis. (2002) (8)
Acute Rheumatic Fever in Tunisia (1997) (6)
Rheumatic fever at the end of the twentieth century: Why is there still a problem? (1992) (5)
Current status of rheumatic fever control programs in the United States. (1981) (5)
Prevention of bacterial endocarditis. (1977) (5)
Infective Endocarditis in Children: The Changing Profile (1989) (4)
Controlling rheumatic heart disease in developing countries. (2006) (4)
Public health implications of group A streptococcal infections in the 1990s (1994) (4)
Acute rheumatic fever. (1978) (4)
Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis : 2012 Update by the Infectious Diseases Society of Americaa (2012) (3)
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases. (2007) (3)
Tick-Borne Tularemia Presenting as Ulcerative Lymphadenitis (1979) (3)
A pilot study for the primary prevention of rheumatic fever in Kosrae, Federated States of Micronesia. (2010) (3)
Failure of prophylaxis for bacterial endocarditis: American Heart Association registry. (1979) (3)
Treatment of adults with acute pharyngitis in primary care practice. (2006) (2)
Rheumatic fever in the United States: no longer a disease of the past. (1988) (2)
Failure of prophylaxis for bacterial endocarditis: American Heart Association Registry. (1980) (2)
Strep throat over and over: how frequent? How real? (2006) (2)
A Managed Care Model for Home Infusion Therapy (1995) (1)
Infective Endocarditis: Aspects Unique to Children and of Special Interest to Pediatric Cardiologists (1986) (1)
Prevention of bacterial endocarditis: a statement prepared by the Committee on Prevention of Rheumatic Fever and Bacterial Endocarditis of the American Heart Association. (1977) (1)
Failure of prophylaxis for bacterial endocarditis: American Heart Association Registry. (1980) (1)
S10-5 RHEUMATIC FEVER: 6 DECADES AFTER JONES CRITERIA (2007) (1)
ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases. (2007) (1)
Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the young, the American Heart Association. (1989) (1)
TABLE OF ORGANIZATION Ad Hoc Committee to revise the Jones Criteria ( modified ) of the Council on Rheumatic Fever and Congeni (2005) (0)
Important announcement from the American Heart Association. (1979) (0)
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. (2007) (0)
Failure of prophylaxis for bacterial endocarditis: American Heart Association Registry. (1980) (0)
Failure of prophylaxis for bacterial endocarditis: American Heart Association registry. (1980) (0)
Controlling rheumatic heart disease in developing countries : : editorial (2006) (0)
Endocarditis and the irrigating device (1978) (0)
Prevention of Infective Endocarditis: Reconsidering the Facts in the 1990s (1997) (0)
Failure of prophylaxis for bacterial endocarditis: American Heart Association Registry. (1980) (0)
The Influence of the Site of Infection (0)
Prevention of rheumatic fever: primary and secondary prophylaxis (2006) (0)
Failure of prophylaxis for bacterial endocarditis: American Heart Association registry. (1980) (0)
The carditis/cardiomyopathy of rheumatic fever: relationship to pathogenesis. (1992) (0)
C.E.P.—The calcium elevating peptide has bone resorbing activity (1980) (0)
Bacterial endocarditis ... again? (1972) (0)
Rheumatic FeverinMinnesota 11. Evaluation ofHospitalized Patients andUtilization OfaState Rheumatic FeverRegistry (1979) (0)
Rheumatic fever. (1990) (0)
Coronary Artery Fistula (1977) (0)
Production of pyrogenic exotoxins in group a streptococci isolated from patients in Zagreb, Croatia (1992) (0)

This paper list is powered by the following services:

Other Resources About Edward L. Kaplan

en.wikipedia.org

What Schools Are Affiliated With Edward L. Kaplan?

Edward L. Kaplan is affiliated with the following schools:

Edward L. Kaplan's Academic­Influence.com Rankings